Chlordiazepoxide Hcl And Clidinium Bromide Capsule
Product Images NDC 42571-381

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hcl And Clidinium Bromide (NDC 42571-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlrodiazepoxideandclidinium-label.jpg (Chlrodiazepoxideandclidinium Label)

Label for Chlordiazepoxide HCl and Clidinium Bromide Capsules USP, strength 5 mg / 2.5 mg, manufactured by Micro Labs Limited and Micro Labs USA, Inc. The label includes dosage instructions, storage conditions, and packaging information for 100 oral capsules. NDC 42571-381-01 is shown with barcodes.*

FDA Label Image

Chlrodiazepoxideandclidinium-structure.jpg (Chlrodiazepoxideandclidinium Structure)

Chemical structure of chlordiazepoxide hydrochloride, showing its molecular framework with chlorine, methyl, and phenyl groups, as well as the HCl component.*

FDA Label Image

Chlrodiazepoxideandclidinium-structure1.jpg (Chlrodiazepoxideandclidinium Structure1)

Chemical structure of Chlordiazepoxide Hydrochloride and Clidinium Bromide, showing molecular components including bromide ion and phenyl groups attached to the core structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.